Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Liushun Jia, Zhen Zhu, Hongbo Li & Yaofeng Li. (2019) RETRACTED ARTICLE: Shikonin inhibits proliferation, migration, invasion and promotes apoptosis in NCI-N87 cells via inhibition of PI3K/AKT signal pathway. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 2662-2669.
Read now
Read now
Zhenxin Wang, Ni Yin, Zixiang Zhang, Yi Zhang, Guangbo Zhang & Weichang Chen. (2017) Upregulation of T-cell Immunoglobulin and Mucin-Domain Containing-3 (Tim-3) in Monocytes/Macrophages Associates with Gastric Cancer Progression. Immunological Investigations 46:2, pages 134-148.
Read now
Read now
Judith Meza-Junco & Michael B Sawyer. (2012) Metastatic gastric cancer – focus on targeted therapies. Biologics: Targets and Therapy 6, pages 137-146.
Read now
Read now
Articles from other publishers (20)
Giandomenico Roviello, Giuseppe Aprile, Alberto D’Angelo, Luigi Francesco Iannone, Franco Roviello, Karol Polom, Enrico Mini & Martina Catalano. (2021) Human epidermal growth factor receptor 2 (HER2) in advanced gastric cancer: where do we stand?. Gastric Cancer 24:4, pages 765-779.
Crossref
Crossref
Di Wu, Jiang Lv, Ruocong Zhao, Zhiping Wu, Diwei Zheng, Jingxuan Shi, Simiao Lin, Suna Wang, Qiting Wu, Youguo Long, Peng Li & Yao Yao. (2020) PSCA is a target of chimeric antigen receptor T cells in gastric cancer. Biomarker Research 8:1.
Crossref
Crossref
Guo-Cai Li, Xu-Chun Jia, Qing-Chuan Zhao, Hong-Wei Zhang, Peng Yang, Long-Long Xu, Fang-Ning Pang & Jian-Bing Sun. (2020) The expression of epidermal growth factor receptor 1 and human epidermal growth factor receptor 2 based on tumor location affect survival in gastric cancer. Medicine 99:21, pages e20460.
Crossref
Crossref
Defu Zhi, Ting Yang, Jian Yang, Shuang Fu & Shubiao Zhang. (2020) Targeting strategies for superparamagnetic iron oxide nanoparticles in cancer therapy. Acta Biomaterialia 102, pages 13-34.
Crossref
Crossref
Yi-wang Zhang, Dan He, Cui Tan, Min Dong, Lu Zhou & Chun-kui Shao. (2019) Differential expression of HER2 and downstream proteins in prediction of advanced tumor phenotypes and overall survival of patients with Epstein-Barr virus-positive vs. negative gastric cancers. Pathology - Research and Practice 215:11, pages 152675.
Crossref
Crossref
Sameer Al DiffalhaKatherine C. SextonPeter H. WatsonWilliam E. Grizzle. (2019) The Importance of Human Tissue Bioresources in Advancing Biomedical Research. Biopreservation and Biobanking 17:3, pages 209-212.
Crossref
Crossref
Noriko Iwamoto & Takashi Shimada. (2019) Regulated LC-MS/MS bioanalysis technology for therapeutic antibodies and Fc-fusion proteins using structure-indicated approach. Drug Metabolism and Pharmacokinetics 34:1, pages 19-24.
Crossref
Crossref
PrameelaG Chelakkot, Rahul Ravind, K Sruthi & Durgapoorna Menon. (2019) Treatment in resectable non-metastatic adenocarcinoma of stomach: Changing paradigms. Indian Journal of Cancer 56:1, pages 74.
Crossref
Crossref
Jixiang Liu, Yanlei Wei, Shouyong Li, Yujuan Li, Hongxiu Liu, Jingmei Liu & Xinxing Zhu. (2018) MicroRNA‑744 promotes cell apoptosis via targeting B�cell lymphoma‑2 in gastric cancer cell line SGC‑7901. Experimental and Therapeutic Medicine.
Crossref
Crossref
Liying Wang, Hongfeng Zhang, Jiaxin Zheng, Xiaoli Wei, Jingwen Du, Haibo Lu, Qiuying Sun, Weiyu Zhou, Rui Zhang & Yu Han. (2018) Dual silencing of EGFR and HER2 enhances the sensitivity of gastric cancer cells to gefitinib. Molecular Carcinogenesis 57:8, pages 1008-1016.
Crossref
Crossref
Wenhu Liu, Jiangbei Yuan, Zhenzhong Liu, Jianwu Zhang & Jinxia Chang. (2018) Label-Free Quantitative Proteomics Combined with Biological Validation Reveals Activation of Wnt/β-Catenin Pathway Contributing to Trastuzumab Resistance in Gastric Cancer. International Journal of Molecular Sciences 19:7, pages 1981.
Crossref
Crossref
Xiaoqiong Wu, Siqi Chen, Limin Lin, Jiayu Liu, Yanlan Wang, Yumei Li, Qing Li & Zhong Wang. (2018) A Single Domain–Based Anti-Her2 Antibody Has Potent Antitumor Activities. Translational Oncology 11:2, pages 366-373.
Crossref
Crossref
Emi Hifumi, Hiroaki Taguchi, Ryuichi Kato, Mitsue Arakawa, Yoshiki Katayama & Taizo Uda. 2018. Antibody Engineering. Antibody Engineering.
Jing Gao, Haixing Wang, Wanchun Zang, Beifang Li, Guanhua Rao, Lei Li, Yang Yu, Zhongwu Li, Bin Dong, Zhihao Lu, Zhi Jiang & Lin Shen. (2017)
Circulating tumor
DNA
functions as an alternative for tissue to overcome tumor heterogeneity in advanced gastric cancer
. Cancer Science 108:9, pages 1881-1887.
Crossref
Crossref
Emi Hifumi, Hiroaki Taguchi, Ryuichi Kato & Taizo Uda. (2017) Role of the constant region domain in the structural diversity of human antibody light chains. The FASEB Journal 31:4, pages 1668-1677.
Crossref
Crossref
Kashima Arora, Monika Tomar & Vinay Gupta. (2017) An impedimetric response study for the efficient detection of breast cancer specific biomarker CA 15-3 using a tin oxide thin film based immunoelectrode. Analytical Methods 9:46, pages 6549-6559.
Crossref
Crossref
MIAO HE, LIMIN WANG, JUN PU, QIAOZHEN YANG, GANG LI & JIE HAO. (2013) Proliferin-related protein overexpression in SGC-7901 gastric cancer cells inhibits in vitro cell growth and tumorigenesis in nude mice. Oncology Reports 29:6, pages 2243-2248.
Crossref
Crossref
Ozkan Kanat & Bert H. O’Neil. (2013) Metastatic gastric cancer treatment: a little slow but worthy progress. Medical Oncology 30:1.
Crossref
Crossref
Esther Cidon, Sara Ellis, Yasir Inam, Sola Adeleke, Sara Zarif & Tom Geldart. (2013) Molecular Targeted Agents for Gastric Cancer: A Step Forward Towards Personalized Therapy. Cancers 5:4, pages 64-91.
Crossref
Crossref
A-Jin Lee, Sang-Gyung Kim, Hyun-Dong Chae, Geon Ho Lee & Im-Hee Shin. (2012) γδ T cells are increased in the peripheral blood of patients with gastric cancer. Clinica Chimica Acta 413:19-20, pages 1495-1499.
Crossref
Crossref